The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Switch to nilotinib versus continued imatinib in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) with detectable BCR-ABL after 2 or more years on imatinib: ENESTcmr 12-month (mo) follow-up.
Jeffrey Howard Lipton
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Teva
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Bristol-Myers Squibb; Novartis
Timothy P. Hughes
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Research Funding - Bristol-Myers Squibb; CSL; Novartis
Brian Leber
Honoraria - Novartis
Expert Testimony - Novartis
Carmino De Souza
Consultant or Advisory Role - Novartis
Pedro E Dorlhiac-Llacer
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer
Juan Luis Steegmann
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Novartis
Agnes Guerci-Bresler
No relevant relationships to disclose
Anthony P. Schwarer
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Novartis
Francisco Cervantes
Consultant or Advisory Role - Novartis
Honoraria - Novartis
John Reynolds
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Research Funding - NHMRC Austrailia; Victorian Cancer Agency Austrailia
LaTonya R Collins
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Tomasz K. Szczudlo
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Nelson Spector
Consultant or Advisory Role - Novartis
Research Funding - Novartis